Abstract Purpose of Review In recent years, immune checkpoint inhibitors have been
increasingly used in patients with metastatic cancers with favorable oncological outcomes; …

Abstract The PD‐1/PD‐L1 interaction has emerged as a significant target in cancer
immunotherapy. Current medications include monoclonal antibodies, which have shown …

Abstract Purpose of Review This review highlights the spectrum of neurologic adverse
events seen with use of immune checkpoint inhibitors (ICIs), their potential mechanisms, the …

Immune checkpoint inhibitors (ICIs) have been increasingly used in the treatment of various
types of tumors with favorable results. But these treatments also led to a variety of immune …

Interventions: The patient underwent treatment with steroid and pyridostigmine. Respiratory
rehabilitation was also performed. Outcomes: Dyspnea and muscle weakness improved …

Objective The purpose of the present study is to report the clinical characteristics of
polyradiculoneuropathy induced by immune checkpoint inhibitors (ICIs). Methods We …

Abstract Objective Guillain–Barré syndrome (GBS) induced by immune checkpoint inhibitors
(ICIs) has been occasionally reported in randomized clinical trials (RCTs), but the post …

Immune checkpoint inhibitors (ICIs) have been approved for the treatment of various
malignancies with promising clinical outcomes. Treatment can, however, be accompanied …

Immune checkpoint inhibitors (ICIs) have recently been used as a promising treatment for
cancer, while their toxicity and immune-related side effects can be seen in any organ …

Immune checkpoint inhibitors have been increasingly used in patients with various cancers.
Despite favourable oncological outcomes these treatments have also been associated with …